171 related articles for article (PubMed ID: 31090310)
1. [Analysis on 1 500 adverse reactions of Guizhi Fuling Capsules based on spontaneous response system].
Wei RL; Xie YM; Zhang WL
Zhongguo Zhong Yao Za Zhi; 2019 Apr; 44(7):1497-1502. PubMed ID: 31090310
[TBL] [Abstract][Full Text] [Related]
2. [ADR/AE early warning analysis of Shujin Jianyao Pills based on spontaneous reporting system].
Zhang C; Li PP; Wang LX; Xie YM; Li L
Zhongguo Zhong Yao Za Zhi; 2020 Aug; 45(15):3533-3538. PubMed ID: 32893541
[TBL] [Abstract][Full Text] [Related]
3. [Analysis of adverse reactions and pharmacovigilance research to parenterally administered shuxuening].
Yang W; Xiang YY; Xie YM; Shen H
Zhongguo Zhong Yao Za Zhi; 2013 Sep; 38(18):3013-8. PubMed ID: 24471322
[TBL] [Abstract][Full Text] [Related]
4. [Analysis of adverse drug reaction/adverse event and early warning signal mining of Ginkgo biloba Dropping Pills based on SRS data].
Zhang C; Liu H; Xie YM; Wang Q
Zhongguo Zhong Yao Za Zhi; 2020 May; 45(10):2322-2328. PubMed ID: 32495588
[TBL] [Abstract][Full Text] [Related]
5. [Analysis of adverse reactions risk signal of Xinyuan Capsules based on national ADR monitoring spontaneous reporting system].
Wang LX; Xie YM; Cheng WX; Zhong R; Zhuang YN; Wang Q
Zhongguo Zhong Yao Za Zhi; 2020 May; 45(10):2310-2315. PubMed ID: 32495586
[TBL] [Abstract][Full Text] [Related]
6. [Study of analysis 1 390 adverse drug reactions cases of parenterally administered dengzhan xixin based on China's spontaneous response system].
Li YY; Xiang YY; Xie YM; Shen H
Zhongguo Zhong Yao Za Zhi; 2013 Sep; 38(18):2998-3002. PubMed ID: 24471319
[TBL] [Abstract][Full Text] [Related]
7. [Post-marketing surveillance on Guizhi Fuling Jiaonang based on literature review].
Wang GQ; Gao Y; Liu FM; Wei RL; Xie YM
Zhongguo Zhong Yao Za Zhi; 2018 Feb; 43(4):820-832. PubMed ID: 29600661
[TBL] [Abstract][Full Text] [Related]
8. [Research on early warning signals of adverse drug reactions to parenterally administered xiyanping based on spontaneous reporting system (SRS) data].
Wang ZF; Xiang YY; Xie YM
Zhongguo Zhong Yao Za Zhi; 2013 Sep; 38(18):3008-12. PubMed ID: 24471321
[TBL] [Abstract][Full Text] [Related]
9. [Analysis of adverse reactions of Xianling Gubao preparation based on real world SRS data].
Peng SY; Xie YM; Wang ZF; Zhang YL; Yi DH
Zhongguo Zhong Yao Za Zhi; 2020 May; 45(10):2316-2321. PubMed ID: 32495587
[TBL] [Abstract][Full Text] [Related]
10. [Spontaneous reporting system data analysis of parenterally administered Shenmai].
Wang LX; Xiang YY; Xie YM; Shen H; Ai QH
Zhongguo Zhong Yao Za Zhi; 2013 Sep; 38(18):2987-93. PubMed ID: 24471317
[TBL] [Abstract][Full Text] [Related]
11. [Study of integrative evidence chain in clinical trial of Guizhi Fuling Capsules based on "Yibing Tongzhi" in clinical applications].
Gao Y; Wang GQ; Xie YM; Wei RL; Liu FM
Zhongguo Zhong Yao Za Zhi; 2020 May; 45(10):2304-2309. PubMed ID: 32495585
[TBL] [Abstract][Full Text] [Related]
12. [Effects and safety of varying doses of guizhi fuling capsule in patients with primary dysmenorrhea: a multi-center, randomized, double-blind, placebo-controlled clinical study].
Liu YJ; Xiao W; Wang ZZ; Zhao BJ; Zhou ZM; Jiang HZ; Jin Z; Wei SB; Wang Z; Wang DM; Xia QH; Lin J; Wang Q
Zhongguo Zhong Yao Za Zhi; 2013 Jun; 38(12):2019-22. PubMed ID: 24066604
[TBL] [Abstract][Full Text] [Related]
13. [Guizhi Fuling capsule / pill treatment for chronic pelvic inflammatory disease：a systematic review of randomized clinical trials].
Zhang LS; Yang FW; Zhang JH; Zheng WK; Zhang MY; Li Y; Zhao HJ
Zhongguo Zhong Yao Za Zhi; 2017 Apr; 42(8):1500-1509. PubMed ID: 29071853
[TBL] [Abstract][Full Text] [Related]
14. [Pharmacovigilance of parenterally administered salvianolate based on analysis of spontaneous reporting system data].
Lu PF; Xiang YY; Xie YM; Chang YP; Wang ZG
Zhongguo Zhong Yao Za Zhi; 2013 Sep; 38(18):3003-7. PubMed ID: 24471320
[TBL] [Abstract][Full Text] [Related]
15. [Spontaneous reportintg system data based on shuxuetong injection adverse reactions signal warning analysis].
Jiang JJ; Xiang YY; Xie YM; Shen H
Zhongguo Zhong Yao Za Zhi; 2013 Sep; 38(18):2994-7. PubMed ID: 24471318
[TBL] [Abstract][Full Text] [Related]
16. Guizhi Fuling Formulation: A review on chemical constituents, quality control, pharmacokinetic studies, pharmacological properties, adverse reactions and clinical applications.
Liu X; Chen L; Sun P; Zhan Z; Wang J
J Ethnopharmacol; 2024 Jan; 319(Pt 2):117277. PubMed ID: 37802375
[TBL] [Abstract][Full Text] [Related]
17. [Predictive model for hygroscopicity of contents in Guizhi Fuling Capsules].
Wang Q; Xu B; Wang F; Xu FF; Zhang X; Zhang YC; DU H; Xia CY; Bao LW; Wang ZZ; Qiao YJ; Xiao W
Zhongguo Zhong Yao Za Zhi; 2020 Jan; 45(2):242-249. PubMed ID: 32237305
[TBL] [Abstract][Full Text] [Related]
18. Metabolomics Study of Guizhi Fuling Capsules in Rats With Cold Coagulation Dysmenorrhea.
Zhang Y; Su N; Liu W; Wang Q; Sun J; Peng Y
Front Pharmacol; 2021; 12():764904. PubMed ID: 34776980
[TBL] [Abstract][Full Text] [Related]
19. [Dissolution test and evaluation of Guizhi Fuling Capsules].
Huang ZB; Wang L; Kang Y; Wang TJ; Wang ZZ; Zhang HD; Bai G; Li Z; Li WL
Zhongguo Zhong Yao Za Zhi; 2022 Oct; 47(19):5256-5263. PubMed ID: 36472032
[TBL] [Abstract][Full Text] [Related]
20. Toxicity Spectrum of Anti-GD2 Immunotherapy: A Real-World Study Leveraging the US Food and Drug Administration Adverse Event Reporting System.
Wang G; Wang J; Du R; Wang Y; Li Z
Paediatr Drugs; 2024 Mar; 26(2):175-185. PubMed ID: 38153627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
